PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsTarenflurbil
Tarenflurbil
Tarenflurbil is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
102 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postoperative painD010149—G89.181——4813
PainD010146EFO_0003843R52—1—438
Low back painD017116HP_0003419M54.5—1—113
Back painD001416HP_0003418M54—1—113
AgnosiaD000377HP_0030222F88—11113
Patient-controlled analgesiaD016058———11113
Chronic periodontitisD055113EFO_0006343K05.3—2—1—3
PeriodontitisD010518EFO_0000649K05.3—2—1—3
DepressionD003863—F33.9———112
Postoperative complicationsD011183—————112
Show 12 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PharyngitisD010612—R07.0—13——4
Alzheimer diseaseD000544EFO_0000249F03——3——3
DementiaD003704EFO_0003862F03——2——2
Esophageal neoplasmsD004938—C15—11——1
Anesthesia and analgesiaD000760———11——1
Simian acquired immunodeficiency syndromeD016097———11——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———121——214
InflammationD007249MP_0001845——1———1
LaryngitisD007827———1———1
Prostatic neoplasmsD011471—C61—1———1
RecurrenceD012008———1———1
Multiple sclerosisD009103EFO_0003885G35—1———1
Relapsing-remitting multiple sclerosisD020529EFO_0003929——1———1
SclerosisD012598———1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Drug interactionsD004347——3———25
ArthritisD001168HP_0001369M05-M143———14
Hiv infectionsD015658EFO_0000764B203————3
Rheumatoid arthritisD001172EFO_0000685M06.93————3
InfectionsD007239EFO_0000544—2————2
Mitochondrial diseasesD028361EFO_0000591—1————1
LeukemiaD007938—C951————1
Myeloid leukemia acuteD015470—C92.01————1
Myeloid leukemiaD007951—C921————1
Acquired immunodeficiency syndromeD000163EFO_0000765B201————1
Show 14 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AnesthesiaD000758——————44
PancreatitisD010195HP_0001733K85————33
Chronic pancreatitisD050500EFO_0000342K86.1————33
Postoperative nausea and vomitingD020250EFO_0004888—————22
VomitingD014839HP_0002013R11.1————22
Drug-related side effects and adverse reactionsD064420—T88.7————11
Migraine disordersD008881EFO_0003821G43————11
HeadacheD006261HP_0002315R51————11
TendinopathyD052256EFO_1001434M77.9————11
SynovitisD013585EFO_0008997M67.5————11
Show 27 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTarenflurbil
INNtarenflurbil
Description
(R)-flurbiprofen is a flurbiprofen. It is an enantiomer of a (S)-flurbiprofen.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1
Identifiers
PDB—
CAS-ID51543-40-9
RxCUI—
ChEMBL IDCHEMBL190083
ChEBI ID38666
PubChem CID92337
DrugBank—
UNII ID501W00OOWA (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 501 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use